Green Cross leads in manufacturing biopharmaceutical products

Published: 2016-05-25 15:18:29

Updated: 2016-05-25 15:18:29

Under the favorable conditions on vaccines and blood products, Green Cross has remained as the top in the biopharmaceutical manufacturing performance.

According to the ‘2015 Biopharmaceutical Manufacturing Performance’ aggregated by the Ministry of Food and Drug Safety, Green Cross recorded a KRW 491.1 billion manufacturing performance last year, increased by 9.3% from KRW 449.5 billion in 20...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.